City

Beijing (1)

Changsha (1)

Chengdu (1)

Chongqing (1)

Guangzhou (1)

Los Angeles (1)

Nanjing (1)

Pittsburgh (1)

Riyadh (1)

Condition

Retinal Disorders (3)

Diabetes (1)

Diabetic Eye Problems (1)

Diabetic Retinopathy (1)

Overall Status

Completed (3)

Sign in for free

Phase

n/a (1)

phase 2 (1)

Sponsor

Chengdu University of Traditional Chinese Medicine (1)

King Khaled Eye Specialist Hospital (1)

University of California, Los Angeles (1)

Collaborator

Chongqing Taiji Group of Fuling pharmaceutical Co., LTD (1)

Jules Stein Eye Institute (1)

National Eye Institute (NEI) (1)

Neurolign (1)

Intervention

needle (1)

pars plana vitrectomy (1)

placebo comparator (1)

pupillometry testing. (1)

qideng mingmu capsule (1)

Study Documents

Intervention Type

device (2)

drug (1)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

retinal disorders

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Retinal Disorders Trial in Riyadh (needle, Pars Plana Vitrectomy)

Completed

Retinal Disorders

needle
Pars Plana Vitrectomy

Riyadh, Saudi Arabia

King Khaled Eye Specialist hospital

Nov 21, 2021

Rapid, Non-invasive, Regional Functional Imaging of Retina.

Completed

Diabetes
Retinal Disorders

Pupillometry testing.

Los Angeles, California
+1 more

Oct 11, 2018

Diabetic Retinopathy, Diabetic Eye Problems, Retinal Disorders Trial in China (Qideng Mingmu capsule, Placebo Comparator)

Completed

Diabetic Retinopathy
+2 more

Qideng Mingmu capsule
Placebo Comparator

Beijing, Beijing, China
+7 more

May 10, 2013